Recent publications on Cancer

Beaber EF, Sprague BL, Tosteson ANA, Haas JS, Onega T, Schapira MM, McCarthy AM, Li CI, Herschorn SD, Lehman CD, Wernli KJ, Barlow WE. Multilevel predictors of continued adherence to breast cancer screening among women ages 50-74 years in a screening population. J Womens Health (Larchmt). 2018 Nov 27. doi: 10.1089/jwh.2018.6997. [Epub ahead of print]. PubMed

Chubak J, McLerran D, Zheng Y, Singal AG, Corley DA, Doria-Rose VP, Doubeni CA, Kamineni A, Haas JS, Halm EA, Skinner CS, Zauber AG, Wernli KJ, Beaber EF. Receipt of colonoscopy following diagnosis of advanced adenomas: an analysis within integrated healthcare delivery systems. lid - 10.1158/1055-9965.epi-18-0452 [doi]  Cancer Epidemiol Biomarkers Prev. 2018 Nov 20. pii: 1055-9965.EPI-18-0452. doi: 10.1158/1055-9965.EPI-18-0452 [Epub ahead of print] PubMed

Coury JK, Schneider JL, Green BB, Baldwin LM, Petrik AF, Rivelli JS, Schwartz MR, Coronado GD. Two Medicaid health plans' models and motivations for improving colorectal cancer screening rates. Transl Behav Med. 2018 Nov 16. pii: 5184635. doi: 10.1093/tbm/iby094. [Epub ahead of print]. PubMed

Brentnall AR, Buist DSM, Cuzick J. Competing risks for a diagnosis of invasive breast cancer-reply. JAMA Oncol. 2019 Jan 1;5(1):111. doi: 10.1001/jamaoncol.2018.5102. PubMed

Smith-Bindman R, Poder L, Johnson E, Miglioretti DL. Risk of malignant ovarian cancer based on ultrasonography findings in a large unselected population. JAMA Intern Med. 2018 Nov 12. pii: 2714301. doi: 10.1001/jamainternmed.2018.5113. [Epub ahead of print]. PubMed

Kamineni A, Tiro JA, Beaber EF, Silverberg MJ, Wheeler CM, Chao CR, Chubak J, Skinner CS, Corley DA, Kim JJ, Balasubramanian BA, Doria-Rose VP. Cervical cancer screening research in the PROSPR I Consortium: rationale, methods, and baseline findings from a U.S. cohort. Int J Cancer. 2018 Oct 24. doi: 10.1002/ijc.31940. [Epub ahead of print]. PubMed

Pisu M, Henrikson NB, Banegas MP, Yabroff R. Costs of cancer along the care continuum: what we can expect based on recent literature. Cancer. 2018 Nov 1;124(21):4181-4191. doi: 10.1002/cncr.31643. Epub 2018 Oct 17. PubMed

Green BB. Colorectal cancer control: where have we been and where should we go next? JAMA Intern Med. 2018 Oct 15. pii: 2706173. doi: 10.1001/jamainternmed.2018.4627. [Epub ahead of print]. PubMed

Yu O, Scholes D, Schulze-Rath R, Grafton J, Hansen K, Reed SD. A US population-based study of uterine fibroid diagnosis incidence, trends, and prevalence: 2005-2014. Am J Obstet Gynecol. 2018 Oct 3. pii: S0002-9378(18)30831-7. doi: 10.1016/j.ajog.2018.09.039. [Epub ahead of print]. PubMed

Selby K, Jensen CD, Lee JK, Doubeni CA, Schottinger JE, Zhao WK, Chubak J, Halm E, Ghai NR, Contreras R, Skinner C, Kamineni A, Levin TR, Corley DA. Influence of Varying Quantitative Fecal Immunochemical Test Positivity Thresholds on Colorectal Cancer Detection: A Community-Based Cohort Study.  Ann Intern Med. 2018;169(7):439-447. doi: 10.7326/M18-0244. Epub 2018 Sep 18.  PubMed

Crockett DS, Gourevitch RA, Morris M, Carrell DS, Rose S, Shi Z, Greer JB, Schoen RE, Mehrotra A. Serrated polyp detection is related to training and colonoscopy volume: results from a multicenter study. Endoscopy. 2018 Oct;50(10):984-992. PubMed

Chubak J, Yu O, Ziebell RA, Bowles EJA, Sterrett AT, Fujii MM, Boggs JM, Burnett-Hartman AN, Boudreau DM, Chen L, Floyd JS, Ritzwoller DP, Hubbard RA. Risk of colon cancer recurrence in relation to diabetes. Cancer Causes Control. 2018 Sep 22. pii: 10.1007/s10552-018-1083-3. doi: 10.1007/s10552-018-1083-3. [Epub ahead of print]. PubMed

Lee CI, Zhu W, Onega TL, Germino J, O’Meara ES, Lehman CD, Henderson LM, Haas JS, Kerlikowske K, Sprague BL, Rauscher GH, Tosteson ANA, Alford-Teaster J, Wernli KJ, Miglioretti DL. The effect of digital breast tomosynthesis adoption on facility-level breast cancer screening volume. AJR Am J Roentgenol. 2018 Nov;211(5):957-963. Epub 2018 Sep 20. PubMed

Brentnall AR, Cuzick J, Buist DSM, Bowles EJA. Long-term accuracy of breast cancer risk assessment combining classic risk factors and breast density.  JAMA Oncol. 2018 Apr 5:e180174. doi: 10.1001/jamaoncol.2018.0174. [Epub ahead of print]. PubMed

Huntley JH, Coley RY, Carter HB, Radhakrishnan A, Krakow M, Pollack CE. Clinical evaluation of an individualized risk prediction tool for men on active surveillance for prostate cancer. LID - S0090-4295(18)30903-8 [pii] LID - 10.1016/j.urology.2018.08.021 [doi]  Urology. 2018 Aug 29. pii: S0090-4295(18)30903-8. doi: 10.1016/j.urology.2018.08.021 [Epub ahead of print] PubMed

Figueroa Gray M, Ludman EJ, Beatty T, Rosenberg AR, Wernli KJ. Balancing hope and risk among adolescent and young adult cancer patients with late-stage cancer: a qualitative interview study. J Adolesc Young Adult Oncol. 2018 Dec;7(6):673-680. doi: 10.1089/jayao.2018.0048. Epub 2018 Aug 10. PubMed

Coronado GD, Petrik AF, Vollmer WM, Taplin SH, Keast EM, Fields S, Green BB. Effectiveness of a mailed colorectal cancer screening outreach program in community health clinics: the STOP CRC cluster randomized clinical trial. JAMA Intern Med. 2018 Sep 1;178(9):1174-1181. doi: 10.1001/jamainternmed.2018.3629. PubMed

Ritzwoller DP, Fishman PA, Banegas MP, Carroll NM, O'Keeffe-Rosetti M, Cronin AM, Uno H, Hornbrook MC, Hassett MJ. Medical care costs for recurrent versus De Novo stage IV cancer by age at diagnosis. Health Serv Res. 2018 Dec;53(6):5106-5128. doi: 10.1111/1475-6773.13014. Epub 2018 Jul 24. PubMed

Mazor KM, Kamineni A, Roblin DW, Anau J, Robinson BE, Dunlap B, Firneno C, Gallagher TH. Encouraging patients to speak up about problems in cancer care. J Patient Saf. 2018 Jun 27. doi: 10.1097/PTS.0000000000000510. [Epub ahead of print]. PubMed

Moshina N, Sebuodegard S, Lee CI, Akslen LA, Tsuruda KM, Elmore JG, Hofvind S. Automated volumetric analysis of mammographic density in a screening setting: worse outcomes for women with dense breasts.  Radiology. 2018 Jun 26:172972. doi: 10.1148/radiol.2018172972. [Epub ahead of print]. PubMed